About the Device
Oxymend™ is a miniaturized, oxygen-producing bandage that can be placed directly into the wound bed allowing micro-patterned oxygen transport channels to ensure oxygen delivery through the infectious barrier on the wound surface. Oxymend™ has the potential to fundamentally transform chronic wound care.Request a Sample
According to the America Diabetes Association, more than 30 million Americans have diabetes with $1 out of $7 is spent on healthcare for the treatment of diabetes and its complications. In the United States alone, $327B is spent per year on diabetes. Oxymend™ is designed to improve the healing and treatment experience associated with chronic wounds such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers.Our Technology
Microfabricated fingerlike projections enabling penetration of biofilm.
Novel catalytic process enables miniaturization and is embedded into the silicone.
Direct, controlled oxygen delivery with on/off switch and adjustable flow rate.
Hermetically sealed to ensure dressing integrity.
An electrochemical cell provides continuous oxygen flow for over 72hrs.
Eco-friendly, disposable design to avoid contamination.
High MobilityWearable 24/7, Slim Profile, Flexible
Low Cost10X Lower Cost Compared to HBOT
ReimbursableQualified as a Reimbursable Wound Dressing
The current density and oxygen production rate as a function of the voltage. A 2.2 cm² electrode was used to conduct potentiodynamic sweeps at 100mV/hour at 20°C. There is a linear correlation between the oxygen production rate and the applied voltage which enables easy control of the oxygen production rate via the use of a resistor. By adjusting the voltage, oxygen production rates can be set and/or adjusted with a 0.5 mL/h accuracy. This gives oxygen production rates of up to 150 mL/h/cm². Oxymend™ will have the capability to deliver over 100 times the estimated flow rate required for treatment of a chronic wound.Learn More
- Animal Study
- Clinical Trial
How Does Oxymend™ Stack Up?
Request a Sample
Disclaimer: Oxymend™ is not FDA cleared and is not currently available for sale. Samples of the device are available for research and development purposes only. Sample requests may be rejected for any reason at our sole discretion.
How can I order this device?
Oxymend™ is not FDA cleared and is not currently available for sale. Samples of the device are available for research and development purposes only. Sample requests may be rejected for any reason at our sole discretion.
Is Oxymend™ an FDA approved product?
No, Oxymend™ is not FDA cleared and is not currently available for sale.
What makes Oxymend™ unique compared to other oxygen wound therapy products?
Oxymend™ has a novel, microfabricated fingerlike projections enabling penetration of biofilm and direct, controlled oxygen delivery. Oxymend™ also offers greater comfort and mobility for long-term wear due to its slim profile design that could fit in your pocket.
How much does Oxymend™ cost?
Detailed pricing information is not yet available as the product is currently not for sale. We expect treatment costs to be a fraction of the cost compared to HBOT while outperforming it.
When will Oxymend™ be available for purchase?
We hope to launch Oxymend™ by late 2020 (subject to FDA approval).